These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25584043)

  • 1. REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER.
    Sreevalsan S; Safe S
    Curr Colorectal Cancer Rep; 2013 Dec; 9(4):350-357. PubMed ID: 25584043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.
    Gandhy SU; Kim K; Larsen L; Rosengren RJ; Safe S
    BMC Cancer; 2012 Nov; 12():564. PubMed ID: 23194063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.
    Pathi SS; Jutooru I; Chadalapaka G; Sreevalsan S; Anand S; Thatcher GR; Safe S
    Mol Cancer Res; 2011 Feb; 9(2):195-202. PubMed ID: 21156786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis.
    Safe S
    Curr Pharmacol Rep; 2015 Apr; 1(2):73-78. PubMed ID: 26457240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors.
    Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S
    Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
    Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
    BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents.
    Jutooru I; Guthrie AS; Chadalapaka G; Pathi S; Kim K; Burghardt R; Jin UH; Safe S
    Mol Cell Biol; 2014 Jul; 34(13):2382-95. PubMed ID: 24732804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.
    Noratto GD; Jutooru I; Safe S; Angel-Morales G; Mertens-Talcott SU
    Mol Nutr Food Res; 2013 Sep; 57(9):1638-48. PubMed ID: 23471840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a.
    Li W; Liu M; Xu YF; Feng Y; Che JP; Wang GC; Zheng JH
    Oncol Rep; 2014 Jan; 31(1):117-24. PubMed ID: 24173369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a.
    Del Follo-Martinez A; Banerjee N; Li X; Safe S; Mertens-Talcott S
    Nutr Cancer; 2013; 65(3):494-504. PubMed ID: 23530649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
    Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
    Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.
    Chadalapaka G; Jutooru I; Safe S
    Carcinogenesis; 2012 Apr; 33(4):886-94. PubMed ID: 22334592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors.
    Kasiappan R; Jutooru I; Mohankumar K; Karki K; Lacey A; Safe S
    Mol Cancer Res; 2019 Mar; 17(3):794-805. PubMed ID: 30610105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs.
    Safe SH; Prather PL; Brents LK; Chadalapaka G; Jutooru I
    Anticancer Agents Med Chem; 2012 Dec; 12(10):1211-20. PubMed ID: 22583404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
    Kim K; Chadalapaka G; Pathi SS; Jin UH; Lee JS; Park YY; Cho SG; Chintharlapalli S; Safe S
    Mol Cancer Ther; 2012 Sep; 11(9):1852-62. PubMed ID: 22752225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
    Li X; Pathi SS; Safe S
    BMC Cancer; 2015 Dec; 15():974. PubMed ID: 26673922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors.
    Hedrick E; Li X; Safe S
    Mol Cancer Ther; 2017 Jan; 16(1):205-216. PubMed ID: 27811009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors.
    Nair V; Pathi S; Jutooru I; Sreevalsan S; Basha R; Abdelrahim M; Samudio I; Safe S
    Carcinogenesis; 2013 Dec; 34(12):2870-9. PubMed ID: 23803693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Products as Mechanism-based Anticancer Agents: Sp Transcription Factors as Targets.
    Safe S; Kasiappan R
    Phytother Res; 2016 Nov; 30(11):1723-1732. PubMed ID: 27384261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.
    Hedrick E; Cheng Y; Jin UH; Kim K; Safe S
    Oncotarget; 2016 Apr; 7(16):22245-56. PubMed ID: 26967243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.